Skip to main content

Table 2 The clinical manifestations of TPP patients with KCNJ18 gene mutations

From: The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis

Case Gender / age Attack duration Symptoms of weakness Hyperthyroidism Potassium mmol / L CK IU / L TSH uIU / ml FT3 pg / ml FT4 ng / dl KCNJ18 mutation
1 Male/19 2 h Quadriplegia Weight loss, goiter 1.9 2093 <0.03 8.2 3.5 p.Q126X
2 Male/20 6 h Quadriplegia Weight loss 2.4 1476 <0.03 12.3 5.8 p.A200P
3 Male/23 3 h Quadriplegia Tremor 2.1 1205 <0.03 7.6 5.1 p.K360T
4 Male/25 8 h Quadriplegia Weight loss 1.6 2310 <0.03 16.8 9.3 p. E388K
  1. Abbreviation: CK creatine kinase, TSH Thyroid Stimulating Hormone, FT3 free triiodothyronine, FT4 free thyroxine.